Novexatin (NP213) is a rapidly acting, novel, first-in-class synthetic antimicrobial peptide (AMP), has anti-fungal activities. NP213 targets the fungal cytoplasmic membrane and plays its role via membrane perturbation and disruption. NP213 is effective and well-tolerated in resolving nail fungal infections.
CAT No: R1890
CAS No: 942577-31-3
Synonyms/Alias: Novexatin;942577-31-3;NP213;2-[3-[(2S,5S,8S,11S,14S,17S,20S)-5,8,11,14,17,20-hexakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,18,21-heptaoxo-1,4,7,10,13,16,19-heptazacyclohenicos-2-yl]propyl]guanidine;CHEMBL2203696;SCHEMBL19712180;EX-A7462;AKOS040764209;DA-76279;HY-126810;CS-0107537;1,1',1'',1''',1'''',1''''',1''''''-(((2S,5S,8S,11S,14S,17S,20S)-3,6,9,12,15,18,21-Heptaoxo-1,4,7,10,13,16,19-heptaazacyclohenicosane-2,5,8,11,14,17,20-heptayl)heptakis(propane-3,1-diyl))heptaguanidine;
Chemical Name: 2-[3-[(2S,5S,8S,11S,14S,17S,20S)-5,8,11,14,17,20-hexakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,18,21-heptaoxo-1,4,7,10,13,16,19-heptazacyclohenicos-2-yl]propyl]guanidine
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C42H84N28O7 |
M.W/Mr. | 1093.3 |
Sequence | Three Letter Code:cyclo[Arg-Arg-Arg-Arg-Arg-Arg-Arg] |
Appearance | Solid powder |
Purity | >98% |
Long-term Storage Conditions | 10 mM in DMSO |
Shipping Condition | RT, or blue ice upon request. |
InChI | InChI=1S/C42H84N28O7/c43-36(44)57-15-1-8-22-29(71)65-24(10-3-17-59-38(47)48)31(73)67-26(12-5-19-61-40(51)52)33(75)69-28(14-7-21-63-42(55)56)35(77)70-27(13-6-20-62-41(53)54)34(76)68-25(11-4-18-60-39(49)50)32(74)66-23(30(72)64-22)9-2-16-58-37(45)46/h22-28H,1-21H2,(H,64,72)(H,65,71)(H,66,74)(H,67,73)(H,68,76)(H,69,75)(H,70,77)(H4,43,44,57)(H4,45,46,58)(H4,47,48,59)(H4,49,50,60)(H4,51,52,61)(H4,53,54,62)(H4,55,56,63)/t22-,23-,24-,25-,26-,27-,28-/m0/s1 |
InChI Key | NVZLKNHDHPPJHL-RMIXPHLWSA-N |
Canonical SMILES | N/C(N)=N\CCC[C@@H](C(N[C@@H](CCC/N=C(N)\N)C(N[C@@H](CCC/N=C(N)\N)C(N[C@@H](CCC/N=C(N)\N)C(N[C@@H](CCC/N=C(N)\N)C(N[C@@H](CCC/N=C(N)\N)C(N[C@H]1CCC/N=C(N)\N)=O)=O)=O)=O)=O)=O)NC1=O |
3. High fat diet and GLP-1 drugs induce pancreatic injury in mice
4. Cationic cell-penetrating peptides are potent furin inhibitors
5. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com